CFDA Exposure Draft on “Simplify Registration Process of Traditional Chinese Medicine Famous Prescription& Compound Preparation (Exposure Draft)” and the Opinions on Registration Material Requirement (Exposure Draft)

• Pre 2017-10-18
  CFDA Exposure Draft on Opinions of “Simplify Registration Process of Drug Manufacturing Location Changing” and “Guidance of Drug Manufacturing Location Changing Research Technology (Exposure Draft)”
• Next 2017-10-09
  Policy Graphics Interpretation: “Opinions on Deepen Medical Examination and Approval System and Encourage Medical Device Innovation”